After about 17 years at Portola Pharmaceuticals, Pamela Conley was ready for her next venture once helping transition some of the drugmaker’s programs into Alexion in mid-to-late 2020.
Since then, she’s been setting up shop at autoimmune-focused Nuvig Therapeutics, which broke cover Wednesday with $47 million from Novo Holdings, Platanus,...
